Comparing the Renal Effect of Dipeptidyl-peptidase 4 Inhibitors and Sulfonylureas
A phase 4 trial registered on ClinicalTrials.gov. The registry status is completed. It enrolled 101 participants.
Also called NCT03983551
- Study
- In this atlas
Overview
- Design
- Interventional study; non-randomized; no masking; primary purpose treatment
- Phase
- Phase 4
- Enrolled
- 101 participants
- Sponsor
- Registry
-
NCT03983551
-
- Started
- (actual)
- Primary completion
- (actual)
- Completion
- (actual)
- Countries
- Not reported
- Registry status
- Completed
Technical summary
Registry record NCT03983551. Non-randomized; no masking; primary purpose treatment. Start 2016-03-01 (actual); primary completion 2018-02-10 (actual). Results not posted.
The registry's words
Labels as the registry gives them, not rewritten.
- Brief title
- Comparing the Renal Effect of Dipeptidyl-peptidase 4 Inhibitors and Sulfonylureas
- Condition
- Type 2 Diabetes Mellitus
- Condition
- Proteinuria
- Intervention (Drug)
- Dipeptidyl Peptidase 4 Inhibitor
- Intervention (Drug)
- Sulfonylurea
- Lead sponsor
- Changhua Christian Hospital
Record details
- Record id
cardio:ct-nct03983551- Content hash
d66add7ff56888e7b06c7033aa3f74fedefa0fcb276b9ee32390bd58c3b026e4